Medication shortages in the Netherlands have led to serious incidents, including irreversible harm to patients, according to ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

PFE's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the ...